Greece vs Iceland: Cause of death, by non-communicable diseases, ages 0-4, male
Greece
40.6%
in 2021
Iceland
40.1%
in 2021
Greece rank
43rd
Iceland rank
46th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Greece
- Iceland
How they compare
Greece currently reports 40.6% against 40.1% in Iceland, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iceland ahead.
Greece ranks 43rd and Iceland ranks 46th of 185 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.1% | 50.7% | 7.6% | Iceland |
| 2010s | 42.1% | 50.8% | 8.6% | Iceland |
| 2020s | 38.7% | 40.3% | 1.5% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Greece or Iceland?
- Greece, at 40.6% against 40.1% in Iceland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Greece and Iceland?
- 0.5%, with Greece ahead.
- How many years of comparable data are there for Greece and Iceland?
- 6 years are reported by both, from 2000 to 2021.
- How do Greece and Iceland rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Greece ranks 43rd and Iceland ranks 46th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.